HBIO
Price
$2.24
Change
+$0.07 (+3.23%)
Updated
Nov 14, 03:22 PM (EDT)
112 days until earnings call
SGHT
Price
$3.86
Change
-$0.12 (-3.02%)
Updated
Nov 14, 04:00 PM (EDT)
126 days until earnings call
Ad is loading...

HBIO vs SGHT

Header iconHBIO vs SGHT Comparison
Open Charts HBIO vs SGHTBanner chart's image
Harvard Bioscience
Price$2.24
Change+$0.07 (+3.23%)
Volume$250
CapitalizationN/A
Sight Sciences
Price$3.86
Change-$0.12 (-3.02%)
Volume$66.1K
CapitalizationN/A
HBIO vs SGHT Comparison Chart
Loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SGHT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
HBIO vs. SGHT commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBIO is a Buy and SGHT is a Hold.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (HBIO: $2.17 vs. SGHT: $3.98)
Brand notoriety: HBIO and SGHT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HBIO: 168% vs. SGHT: 132%
Market capitalization -- HBIO: $184.01M vs. SGHT: $264.12M
HBIO [@Medical Specialties] is valued at $184.01M. SGHT’s [@Medical Specialties] market capitalization is $264.12M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HBIO’s FA Score shows that 1 FA rating(s) are green whileSGHT’s FA Score has 0 green FA rating(s).

  • HBIO’s FA Score: 1 green, 4 red.
  • SGHT’s FA Score: 0 green, 5 red.
According to our system of comparison, SGHT is a better buy in the long-term than HBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HBIO’s TA Score shows that 2 TA indicator(s) are bullish while SGHT’s TA Score has 4 bullish TA indicator(s).

  • HBIO’s TA Score: 2 bullish, 7 bearish.
  • SGHT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SGHT is a better buy in the short-term than HBIO.

Price Growth

HBIO (@Medical Specialties) experienced а -23.05% price change this week, while SGHT (@Medical Specialties) price change was -21.96% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.85%. For the same industry, the average monthly price growth was +1.00%, and the average quarterly price growth was -4.44%.

Reported Earning Dates

HBIO is expected to report earnings on Mar 06, 2025.

SGHT is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Medical Specialties (-1.85% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGHT($264M) has a higher market cap than HBIO($184M). SGHT YTD gains are higher at: -22.868 vs. HBIO (-59.439). HBIO has higher annual earnings (EBITDA): 8.03M vs. SGHT (-49.42M). SGHT has more cash in the bank: 138M vs. HBIO (4.28M). SGHT has less debt than HBIO: SGHT (35.4M) vs HBIO (42.8M). HBIO has higher revenues than SGHT: HBIO (112M) vs SGHT (81.1M).
HBIOSGHTHBIO / SGHT
Capitalization184M264M70%
EBITDA8.03M-49.42M-16%
Gain YTD-59.439-22.868260%
P/E RatioN/AN/A-
Revenue112M81.1M138%
Total Cash4.28M138M3%
Total Debt42.8M35.4M121%
FUNDAMENTALS RATINGS
HBIO: Fundamental Ratings
HBIO
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HBIOSGHT
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
75%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SGHT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCGVX31.950.14
+0.44%
Sands Capital Global Growth Inv
PETZX15.28N/A
N/A
Gabelli Pet Parents'™
HESGX45.96-0.08
-0.17%
Horizon Defensive Core Investor
MSAWX20.07-0.09
-0.45%
Morgan Stanley Inst Asia Opp C
JACNX32.32-0.29
-0.89%
Janus Henderson Contrarian D

HBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HBIO has been loosely correlated with CTKB. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HBIO jumps, then CTKB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HBIO
1D Price
Change %
HBIO100%
-4.82%
CTKB - HBIO
49%
Loosely correlated
-3.69%
XRAY - HBIO
46%
Loosely correlated
-2.42%
CRL - HBIO
44%
Loosely correlated
-4.35%
KIDS - HBIO
44%
Loosely correlated
+0.87%
PACB - HBIO
42%
Loosely correlated
-10.20%
More